Jefferies Group LLC Gsk PLC Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $1.38 Million - $2.07 Million	-42,376 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $841,596 - $966,833	-20,038 Reduced 32.1%	42,376 $1.99 Million
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $608,599 - $654,627	-15,042 Reduced 19.42%	62,414 $2.66 Million
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $3.05 Million - $3.31 Million	77,456 New	77,456 $3.1 Million
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $83,077 - $89,222	-2,090 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $82,784 - $89,368	2,090 New	2,090 $84,000
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $2.97 Million - $3.3 Million	-82,162 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $2.9 Million - $3.44 Million	82,162	82,162 $2.91 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.